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Abstract 
Recent advances in the fields of electronics and microfabrication techniques have led to the 
development of implantable medical devices for use within the field of precision medicine. 
Monitoring visceral surface tissue O2 tension (ptO2) by means of an implantable sensor is 
potentially useful in many clinical situations, including the peri-operative management of 
patients undergoing intestinal resection and anastomosis. This concept could provide a 
means by which treatment could be tailored to individual patients. This study describes the 
in vivo validation of a novel miniaturised electrochemical O2 sensor to provide real-time data 
on intestinal ptO2. A single O2 sensor was placed onto the serosal surface of the small intestine 
of anaesthetised rats that were exposed to ischaemic (superior mesenteric artery occlusion) 
and hypoxaemic (alterations in inspired fractional O2 concentrations) insults. Control 
experiments demonstrated that the sensors function and remain stable in an in vivo 
environment. Intestinal ptO2 decreased following superior mesenteric artery occlusion and 
with reductions in inspired O2 concentrations. These results were reversible after reinstating 
blood flow or increasing inspired O2 concentrations. We have successfully developed an 
anaesthetised rat intestinal ischaemic and hypoxic model for validation of a miniaturised O2 
sensor to provide real-time measurement of intestinal ptO2. Our results support further 
validation of the sensors in physiological conditions using a large animal model to provide 
evidence of their use in clinical applications where monitoring visceral surface tissue O2 
tension is important.  
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Introduction 
Precision medicine is beginning to play important roles in the prevention, investigation and 
treatment of a range of diseases as it enables individual patient variability to be considered. 
Precision medicine may be integrated into standard clinical practices in different ways, 
however, recent advances in the fields of electronics and microfabrication techniques have 
led to interest in the use of implantable medical devices for disease diagnosis, treatment and 
monitoring. Pre-clinical research using in vivo murine studies have already shown that 
implantable devices can detect tumour secreted biomarkers (8) or release chemotherapeutic 
drugs directly within tumours (29). The biocompatibility and biofunctionality of implantable 
devices in a range of diseases has also been shown in many studies using in vivo models, 
providing substantial evidence of their increasing potential for clinical applications (15). 
One such implantable medical device is being developed through the Implantable 
Microsystems for Personalised Anti-Cancer Therapy (IMPACT) programme at the University 
of Edinburgh (27). This project has developed a novel miniaturised implantable O2 sensor on 
a silicon chip designed to monitor intra-tumoural O2 levels. The design is based on a Clark 
electrode for the electrochemical detection of O2 which is connected by a lead to external 
instrumentation. Hypoxic tumour areas are more resistant to radio and chemotherapy, 
therefore identifying them by means of an implantable sensor may enable these regions to 
be targeted more efficiently. However, the use of this sensor may not be restricted to cancer 
patients and may have additional applications in which monitoring visceral surface tissue O2 
tension (ptO2) is clinically important. One potential situation where assessment of tissue 
perfusion would be advantageous is in the peri-operative management of patients 
undergoing intestinal surgery. 
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Intestinal resection and anastomosis is a commonly performed abdominal operation for a 
variety of benign and malignant diseases. The procedure involves removal (resection) of a 
segment of intestine with the subsequent re-joining (anastomosis) of the intestinal ends in a 
manner that optimises healing and restores mural and luminal integrity. However, if the 
anastomosis fails to heal and a leak develops, patients suffer a significant increase in 
morbidity (17, 23, 28) and mortality (9). Leak rates can be as high as 24% for surgery 
performed in the distal rectum; however, overall leak incidence is generally accepted to be 
approximately 6-7% (6, 21). The aetiology of an anastomotic leak is multifactorial; however, 
blood flow disruption, leading to compromised tissue perfusion and decreased oxygenation 
is known to affect anastomotic healing through the development of peri-anastomotic necrosis 
(38). Surgeons typically asses intra-operative intestinal perfusion through macroscopic tissue 
appraisal; however, this subjective technique is unable to predict the risk of a leak occurring. 
It is suggested that objective measurements of tissue perfusion at the anastomosis can aid 
the identification of anastomotic sites at increased risk of leakage (24). Methods used to 
assess tissue perfusion (visible light and near infrared spectroscopy and laser fluorescence 
angiography) (13, 19) and oxygen tensions (scanning laser Doppler flowmetry and wireless 
hand held pulse oximeters) (7, 38) have been shown to help predict the occurrence of a leak. 
Visible light spectroscopy has also been shown to be compatible with endoscopic procedures 
(5, 13, 25). Currently there is one clinical trial underway assessing whether the intra-operative 
measurement of anastomotic perfusion using a fluorescent dye (indocyanine green) and near-
infrared laparoscopy can minimise the occurrence of leaks compared with conventional 
white-light laparoscopy (3). Pre-clinical (26, 39) and clinical (40, 41) studies have also shown 
that Clark O2 sensors can not only measure intestinal ptO2, but also predict the occurrence of 
an anastomotic leak. These studies used O2 sensors consisting of a platinum cathode and 
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sliver anode, which were used to measure intra-operative intestinal ptO2. Intra-operative 
measurements were only possible due to the large size of the electrodes used in the pre-
clinical studies (62x7mm, intestinal contact surface 2mm) (39) and because hand held devices 
were used in both clinical studies.  
Unfortunately, none of these techniques are routinely used by clinicians and are only 
applicable to intra-operative use; they cannot be left in situ as a means of real-time, 
continuous, post-operative monitoring. The development of a miniaturised implantable 
device for the continuous intra- and post-operative monitoring of intestinal ptO2 could 
provide an additional means by which anastomotic healing could be monitored, thereby 
providing a means by which peri-operative patient treatment could optimised. In this study 
we describe the development and use of an anaesthetised rat intestinal ischaemic and 
hypoxic model for validation of the IMPACT O2 sensor to provide real-time measurement of 
intestinal ptO2. 
Materials and Methods 
Studies were undertaken under a UK Home Office Project Licence in accordance with the 
Animals (Scientific Procedures) Act 1986 and with approval from the University College 
London Animal Ethics Committee. Male Wistar rats (Charles River Laboratories, Margate, UK) 
of approximately 400 g body weight were used in all experiments (n>4/treatment group). 
Prior to instrumentation, the rats were acclimatised for at least 1 week and housed in cages 
of 4 on an alternating 12 h light/dark cycle with ad libitum access to food and water. 
Rats were anaesthetised using isoflurane (Abbott, Maidenhead, UK) delivered in room air (5% 
for induction, 2% for surgical procedures and 1.5% for maintenance). Rats were placed on a 
heated mat to maintain rectal temperature between 36.5–37.5oC, which was continuously 
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monitored using a temperature sensor (Harvard Apparatus, Cambridge, UK) inserted into the 
rectum. Placement of arterial and venous lines was performed as reported previously (10) 
(Fig.1). The arterial line was subsequently connected to a pressure transducer system 
(Powerlab and Chart 5 acquisition software, AD Instruments, Chalgrove, UK) for continuous 
monitoring and recording of mean arterial blood pressure and heart rate. The arterial line was 
also used for intermittent blood sampling; when required, 0.1 ml of arterial blood was taken 
into heparinised capillary tubes for blood-gas analysis (ABL90 Analyser; Radiometer, 
Copenhagen, Denmark). The venous line was used for administration of fluids; all animals 
received a continuous infusion of 10–20 ml/kg/hr compound sodium lactate (Baxter, 
Thetford, UK) to maintain mean arterial blood pressure at approximately 100 mmHg. A 
tracheostomy was created using 2.08 mm external diameter polythene tubing (Portex Ltd, 
Hythe, UK); this was attached to a T-piece to secure the airway, maintain anaesthesia and to 
allow alterations in the inspired fractional O2 concentration (FiO2). 
 
Figure 1. Intra-operative photographs depicting placement of central venous (jugular) and 
arterial (carotid) lines. a) A 2 cm ventral cervical skin incision is made. b&c) Cervical dissection 
is performed for identification and mobilisation of the right jugular vein. d) One untied suture 
is placed distally around the jugular vein and a second is placed proximally and tied securely, 
leaving approximately 1 cm of vein between the 2 sutures. e) A venotomy is created just distal 
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to the proximal suture; the cannula is inserted and advanced into the vein approximately 2-3 
cm before tying the distal suture around the vein and cannula. f) Cervical dissection is 
performed for identification of the left carotid artery and its isolation from the vagus nerve. 
g) One untied suture is placed distally around the carotid artery and a second is placed 
proximally and tied securely leaving approximately 1.5 cm of artery between the 2 sutures. A 
small clamp is added just proximal to the distal suture before placing a third untied suture. h) 
An arteriotomy is created between the 2 sutures and the cannula is inserted and advanced 
up to the clamp. i) The third suture is tied loosely over the cannula and the clamp is removed. 
j) The cannula is advanced a further 2 cm before tying the distal suture around the artery and 
cannula. Both vessels were cannulated using 0.96 mm outside diameter PVC tubing (Scientific 
Commodities Inc., Lake Havasu City, AZ, USA) and secured in place with 5-0 silk (Ethicon, UK). 
One control group (to assess sensor longevity and baseline drift) and two treatment groups 
(either superior mesenteric artery occlusion, or manipulation of FiO2 and circulating blood 
volume) were used to assess whether the sensor could detect changes in intestinal 
oxygenation following local or systemic cardiorespiratory insults (Fig. 2). A ventral midline 
celiotomy was performed on all animals extending from the pubis to the manubrium and a 
temporary cystotomy was created by making a small stab incision at the apex of the bladder, 
which was then cannulated with 1.57 mm external diameter polythene tubing (Portex Ltd, 
Hythe, UK) and sutured in place. To allow access to the abdominal vasculature and placement 
of the sensor, the caecum and small intestine were exteriorised to the left side on the animal, 
wrapped in cling film (to reduce evaporative fluid and convective heat loss) and kept moist 
with regular topical applications of saline. The O2 sensor was placed on the antimesenteric 
serosal surface of a proximal section of small intestine. The active area of the sensor was kept 
moist and placed at the midpoint between small serosal blood vessels (Fig. 3). The sensor lead 
was temporarily attached to the serosal surface of the bowel using tissue adhesive (Vetbond, 
3M, Bracknell, UK). Following instrumentation, all animals were allowed a period of 
stabilisation of at least 30 min to achieve stable baseline physiological variables. Continuous 
sensor readings were made throughout each experiment, commencing after the initial 
stabilisation period and continuing for 15 min following confirmation of death post-
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euthanasia. All animals were euthanised with intravenous sodium pentobarbitone (Pentoject; 
Animalcare, York, UK). 
 
Figure 2. Outline of experimental protocols and interventions. Protocol 1: Control animals 
with no interventions. Protocol 2: Superior mesenteric artery occlusion. Protocol 3: 
Alterations in FiO2, haemorrhage and autotransfusion (resuscitation). Instrumentation 
encompassed: anaesthesia induction, surgical preparation, placement of arterial and venous 
lines and celiotomy. The sensor was placed on the serosal surface of the small intestine 
approximately half way through the stabilisation period. Continuous sensor readings were 
commenced following the achievement of stable baseline physiological variables and 
continued for 15 min following confirmation of death post-euthanasia. 
 
Figure 3. Sensor picture and intra-operative photographs depicting intestinal placement of 
the sensor. a) Macroscopic image of the IMPACT miniaturised O2 sensor. b) Intra-operative 
sensor placement on the serosal surface of a section of small intestine. 
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Oxygen Sensor Recordings 
The IMPACT O2 sensor contains a complete miniaturised three-electrode cell, with platinum 
working and counter electrodes, and a silver/silver chloride reference electrode. Nafion was 
used to cover the electrode surfaces to reduce electrode biofouling and improve sensor 
lifetime. Electrodes were fabricated on silicon wafers using conventional microfabrication 
techniques, and diced into 2.0 mm x 3.0 mm chips, each of which carried a single sensor 
(Marland et al., manuscript submitted). Chips were wire bonded to a 1.7 mm x 200 mm long 
lead, and the chip was sealed in biocompatible epoxy resin giving an overall sensor size of 
approximately 2.8 mm x 5.0 mm x 1.4 mm (width x length x height), with a clear window over 
the central active area to permit sensor access to the tissue environment. Following intestinal 
placement/implantation, the sensor lead was connected to an EmStat3 Blue potentiostat 
(PalmSens BV, Houten, Netherlands). Periodic O2 measurements were performed using 
chronoamperometry at -0.5 V (versus the on-chip Ag/AgCl reference electrode) for 20 s, 
followed by a rest period of 20 s, repeated continuously for the duration of the experiment. 
The working electrode current over the final 5 s of each chronoamperometry recording was 
averaged using MATLAB R2017a (MathWorks, Natick, MA, USA) to derive the mean current. 
We have previously shown that the measured current magnitude is proportional to local pO2 
at the sensor surface in saline (Marland et al., manuscript submitted). However, since there 
may be small environmental differences between saline and tissue that could affect the slope 
of the sensor response in vivo, we chose to directly quantify its electrode current in this study. 
Protocol 1: Control group 
The control group of animals consisted only of continuous sensor readings taken for 165 min. 
These animals were sham operated, receiving only a ventral midline celiotomy (as described 
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in the previous section) for sensor placement with no superior mesenteric artery (SMA) 
occlusions or manipulations of FiO2 or circulating blood volume being performed (i.e.no 
physiological challenges were performed on these instrumented animals). Arterial blood 
samples were obtained immediately prior to the start of continuous sensor readings, every 
hour thereafter and then just prior to euthanasia. 
Protocol 2: Intestinal tissue responses to temporary superior mesenteric artery occlusion 
For temporary SMA occlusion, the vessel was first identified originating from the left side of 
the aorta at the level of the right renal vein joining the caudal vena cava. The SMA was 
dissected free from surrounding soft tissue and its associated vein as close to its aortic origin 
as possible. A loose suture of 5-0 silk (Ethicon, UK) was placed round the artery for ease of 
location and to allow gentle traction to aid its temporary and reversible mechanical occlusion. 
Following its isolation, the vessel was repeatedly occluded with the use of a haemostatic 
clamp (Fine Science Tools, Linton, UK). Each occlusion was performed for 5 min with a 10 min 
reperfusion period between occlusions. Vessel occlusion was confirmed by loss of pulsations 
in the mesenteric arteries and intestinal pallor. A hyperaemic flush and the presence of 
mesenteric arterial pulsations were evident following removal of the haemostatic clamp. 
Arterial blood samples were obtained immediately prior to the start of continuous sensor 
readings and just before euthanasia. 
Protocol 3: Intestinal tissue responses to alterations in inspired oxygen concentrations, 
progressive haemorrhage and autotransfusion 
FiO2 (1.0, 0.21, 0.1) was varied at 15 min intervals and delivered through a flowmeter via the 
isoflurane vaporiser to maintain adequate anaesthesia. The protocol for varying FiO2 was: 
0.21 for 15 min, 0.1 for 15 min (inducing hypoxaemia), 0.21 for 15 min, 1.0 for 15 min 
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(inducing hyperoxaemia) before returning to 0.21 for 15 min. Arterial blood samples were 
taken at the end of each FiO2 alteration. 
Following completion of the FiO2 modifications, progressive haemorrhage was achieved by 
withdrawing 15% of the animals circulating blood volume (estimated based on 70 ml/kg body 
weight) over 5 min. The animal was allowed to stabilise for 10 min before a further 15% 
circulating blood volume was removed. The exsanguinated blood was collected in a 
heparinised syringe and maintained at 37oC. Autotransfusion was performed by administering 
the exsanguinated blood intravenously to the animal over 10 min. Arterial blood samples 
were taken at the end of each haemorrhage procedure and just before euthanasia. 
Statistical Analysis 
Data was confirmed as normally distributed using the Shapiro-Wilk test and subsequently 
analysed with parametric tests; one-way ANOVA with Holm-Šídák multiple comparisons test 
was used to test for differences between groups; P values <0.05 were deemed statistically 
significant. Data were expressed as mean ± standard error of the mean (SEM). Statistical 
analyses were performed using Prism 7 (GraphPad Software, San Diego, CA, USA). 
Results 
Sensor readings remained stable in control animals 
For assessment of sensor stability, we performed continuous sensor readings in instrumented 
rats which were not subjected to any physiological interventions (n=3). These control 
experiments were of a duration that encompassed the longest experimental protocol. The 
negative currents generated in the O2 sensors are proportional to ptO2, with more negative 
values indicating greater O2 partial pressures. The measured currents were stable over 165 
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min, with mean values ranging from -1.14 ± 0.03 nA at 15 min to -1.44 ± 0.15 nA at 135 min 
(p=0.7244) (Fig. 4a). 
To assess the stability of the rats during anaesthesia, physiological data including core 
temperature (CT), heart rate (HR), respiratory rate (RR) and mean arterial blood pressure 
(MAP) plus intermittent blood-gas and biochemistry samples were evaluated. All 
physiological data, blood-gas analysis and electrolytes remained stable; only blood glucose 
levels decreased slightly towards the end of the procedure. Although this reduction was not 
statistically significant (p= 0.9304) it is consistent with the fasting state and metabolic 
demands of the rat during anaesthesia (Fig 4b). The physiological data obtained, combined 
with arterial blood analysis, provided evidence that the rats were able to cope with the 
physiological demands from general anaesthesia for the duration of our experimental 
protocols. These results are in accordance with other previous studies (11). 
 
Figure 4. Sensor readings and physiological data obtained from control animals (Protocol 
1). a) Current generated at the working electrode of the sensor during continuous sensor 
readings over a period of 165 min; results show mean current readings from the final 5 min 
of each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 
expressed as mean ± SEM, n=3, p=0.7244). b) Physiological data obtained throughout the 
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experimental period (Hb: haemoglobin; ABE: arterial base excess; SaO2: haemoglobin O2 
saturation; PaO2: arterial O2 partial pressure; PaCO2: arterial CO2 partial pressure; CT: core 
temperature; RR: respiratory rate; HR: heart rate). 
Oxygen current generated by the sensor rapidly decreased following occlusion of the 
superior mesenteric artery and was reversible upon reinstatement of blood flow 
To assess whether the sensor could detect changes in intestinal oxygenation through the 
generation of localised tissue ischaemia, we performed three cycles of temporary SMA 
occlusion followed by release in each rat (n=4) (Fig. 5a). After each occlusion, there was an 
almost immediate fall in sensor current from non-occluded readings of -1.85 ± 0.05 nA to 
occluded readings of -0.27 ± 0.08 nA. The decrease in current that occurred during each 
occlusion was statistically significant when compared to current values pre- and post-
occlusion (p= 0.0082). The decrease in current during the occlusion quickly rose back to non-
occluded current levels following reinstatement of blood flow (Fig. 5b and Table I). Following 
euthanasia, sensor readings fell to the lowest recorded, measuring 0.04 ± 0.16 nA; this 
decrease was statistically significant when compared to non-occluded SMA currents (p= 
0.0025) (Fig. 5c). These results showed that the sensor could quickly, reliably and reproducibly 
detect transient intestinal ischaemia. 
14 
 
 
Figure 5. Intra-operative photographs and sensor readings during temporary superior 
mesenteric artery occlusion (Protocol 2). ai) Identification of the SMA originating from the 
left side of the aorta at the level of the right renal vein joining the caudal vena cava; the vessel 
is robust and can withstand the manipulation required for isolation from its surrounding 
tissue and associated vein. aii) A Bulldog clamp was placed across the SMA for temporary 
occlusion. Note the intestinal pallor that was immediately evident upon occlusion. aiii) 
Following removal of the Bulldog clamp and reinstatement of blood flow, a hyperaemic flush 
was evident to the intestines. b) Representative graph showing current generated at the 
working electrode of the sensor during continuous sensor readings over a period of 70 min. 
Three cycles of 5 min occlusion followed by 10 min of reperfusion were performed in each 
animal before euthanasia. c) Combined analysis comparing current generated at the working 
electrode of the sensor during periods of SMA occlusion and intestinal reperfusion; results 
show mean current readings of the final 3 min of each occlusion period and final 5 min of each 
reperfusion period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 
expressed as mean ± SEM, n=4, **p≤0.01). 
 Baseline Occlusion 
(1) 
Reperfusion 
(1) 
Occlusion 
(2) 
Reperfusion 
(2) 
Occlusion 
(3) 
Reperfusion 
(3) 
Euthanasia 
Current 
(nA) 
-1.98 ± 
0.47 
-0.12 ± 
0.25 
-1.73 ± 0.40 -0.41 ± 
0.24 
-1.85 ± 0.36 -0.28 ± 
0.27 
-1.84 ± 0.32 0.04 ± 0.16 
Table I. Current readings generated during each superior mesenteric artery occlusion and 
reperfusion period and euthanasia (n=4; mean ± SEM). 
Oxygen current generated by the sensor responded rapidly to alterations in inspired oxygen 
concentrations 
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To assess whether the sensor could detect changes in intestinal oxygenation through 
alterations in FiO2 we performed sequential inspired O2 challenges varying from 0.1-1.0 (n=5). 
With an FiO2 of 0.21 (breathing room air), the mean sensor current was -1.35 ± 0.06 nA. When 
FiO2 was reduced to 0.1, the sensor current decreased by more than half, to -0.60 ± 0.10 nA. 
This decrease was statistically significant when compared to currents generated when 
breathing room air (p= 0.0396). The decrease in current occurred over 1-2 min and was 
maintained throughout the hypoxaemic challenge. Following restoration of FiO2 to 0.21, the 
current returned to baseline levels over a period of 1-2 min. Upon increasing inspired FiO2 to 
1.0 the sensor current rose to -6.53 ± 0.46 nA, which was statistically significant when 
compared to currents generated with an FiO2 of 0.21 (p< 0.0001). This increase in current was 
again maintained throughout the FiO2 challenge. Returning FiO2 back to room air saw sensor 
currents return to baseline levels. Following euthanasia, sensor readings fell to the lowest 
recorded, measuring -0.08 ± 0.17 nA (Fig 6a). These results showed that the sensor could 
quickly, reliably and reproducibly detect changes in intestinal oxygenation following 
alterations in FiO2 (Fig 6b and Table II). 
Blood-gas analysis at the end of each FiO2 challenge showed the expected physiological 
alterations in arterial O2 partial pressure (PaO2) and haemoglobin O2 saturation (SaO2). Both 
variables decreased significantly at an FiO2 of 0.1, increased significantly at an FiO2 of 1.0 
(more prominent with PaO2), and returned to baseline levels at 0.21. Total haemoglobin (Hb) 
concentration remained constant (Fig. 6c & d). 
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Figure 6. Sensor readings and physiological data obtained from assessing intestinal tissue 
oxygenation following changes in inspired O2 concentrations (Protocol 3A). a) 
Representative graph showing current generated at the working electrode of the sensor 
during continuous sensor readings over a period of 150 min. 15 min blocks of each FiO2 
challenge were performed before beginning the removal of 30% of the circulating blood 
volume. b) Combined analysis comparing current generated at the working electrode of the 
sensor during each FiO2 challenge; results show mean current readings of the final 5 min of 
each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 
expressed as mean ± SEM, n=5, ****p≤0.0001; *p≤0.05). c&d) Arterial O2 partial pressure, 
total haemoglobin and haemoglobin O2 saturation measured at end of each FiO2 challenge. 
 21% (1) 10% 21% (2) 100% 21% (3) Euthanasia 
Current (nA) -1.35 ± 0.18 -0.60 ± 0.10 -1.37 ± 0.12 -6.53 ± 0.46 -1.55 ± 0.20 -0.08 ± 0.17 
Table II. Current readings generated during each FiO2 challenge and euthanasia (n=5; mean ± 
SEM). 
No change in sensor current was identified following progressive haemorrhage 
Following completion of FiO2 challenges, we assessed the ability of the sensor to detect 
changes in intestinal ptO2 following progressive withdrawal of 30% circulating blood volume 
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(performed in 2x 15% removal periods) (n=5) (Fig 7a). Physiological data obtained 10 min after 
the end of each haemorrhage procedure showed the expected physiological response 
occurring from acute haemorrhage: HR, MAP and Hb concentration all showed a moderate 
decrease after 15% removal, which was even more pronounced after 30%; HR decreased from 
405 ± 22 bpm to 348 ± 16 bpm, MAP decreased from 118 ± 12 mmHg to 56 ± 3 mmHg, and 
Hb decreased from 13.3 ± 0.6 g/dl to 11.4 ± 0.4 g/dl. All of these physiological parameters 
returned to baseline levels following autotransfusion (Fig. 7b & c). SaO2 remained constant 
throughout each haemorrhage procedure. 
Despite these expected physiological responses to acute haemorrhage, only a small and non-
significant decrease in sensor current was observed. Baseline measurements were -1.55 ± 
0.20 nA; however, following 15% and 30% haemorrhage currents only decreased to -1.39 ± 
0.13 nA and -1.33 ± 0.13 nA respectively. Following autotransfusion, no statistically significant 
changes in sensor current occurred, measuring -1.22 ± 0.14 nA at the end of the transfusion 
(Table III). 
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Figure 7. Sensor readings and physiological data obtained from assessing intestinal tissue 
oxygenation following progressive haemorrhage and autotransfusion (Protocol 3B). a) 
Combined analysis comparing current generated at the working electrode of the sensor 
during the preceding 15 min baseline period at 21% O2 and the subsequent 2 cycles of removal 
of 15% circulating blood volume followed by autotransfusion; results show mean current 
readings of the final 5 min of each period (one-way ANOVA with Holm-Šídák’s multiple 
comparisons test; data expressed as mean ± SEM, n=5). b&c) Mean arterial blood pressure, 
heart rate, total haemoglobin and haemoglobin O2 saturation measured at end of each of 
intervention period (haem: haemorrhage; Resus: autotransfusion resuscitation). 
 Baseline 15% haemorrhage 30% haemorrhage Autotransfusion 
Current (nA) -1.55 ± 0.20 -1.39 ± 0.13 -1.33 ± 0.13 -1.22 ± 0.14 
Table III. Current readings generated during 21% FiO2, each haemorrhage procedure and 
autotransfusion (n=5; mean ± SEM). 
Discussion 
For validation and proof-of-concept that the IMPACT O2 sensor can provide real-time 
measurements of intestinal ptO2 we developed an in vivo intestinal ischaemic (SMA occlusion) 
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and hypoxic (changes in FiO2) model. Control experiments were first used to demonstrate 
that the rats could remain physiologically stable under general anaesthesia and that the 
sensors provided stable measurements. These experiments also allowed us to rule out 
potential effects of the tissue environment on sensor stability; the design and packaging of 
the IMPACT O2 sensor is likely to have minimised this potential problem. The outer protective 
coating is made from Nafion, an ionomer made by the addition of sulfonic acid groups to 
Teflon. Nafion membranes are commonly used in a variety of implantable devices due to the 
selectively of substances which diffuse through it. The pore size within the membrane is 
sufficiently small to exclude macromolecules such as proteins that may contaminate the 
electrode surface, while the presence of charged sulphonate groups leads to the electrostatic 
exclusion of small anions (34). 
Our sensors were placed onto the intestinal serosal surface and secured with tissue glue. This 
technique avoided the use of constant manual pressure on the sensor which could interfere 
with intestinal blood supply leading to alterations in ptO2 measurements (40). The tissue area 
from which the electrode measures ptO2 is related to electrode size, a matter which needs to 
be considered if Clark electrodes are used for clinical applications. The working electrode 
(where O2 is detected) of the IMPACT O2 sensor has a diameter of 50 µm. This small sensing 
area means the sensor will not significantly deplete tissue O2 levels, while also allowing for 
accurate sensor placement to specific areas by the surgeon. Use of multiple sensors would 
provide ptO2 readings from a larger area, which is advantageous for anastomotic surgery as 
sensors could be placed around the anastomotic circumference and at either side of the 
resection site, giving detailed peri-anastomotic ptO2 information. Such detailed information 
could not be achieved using a sensor with a large working area that gives only mean ptO2 
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readings from multiple capillary beds, as is likely the case in the pre-clinical and clinical studies 
using Clark electrodes described in the introduction. 
The SMA is the principal arterial supply to a large part of the gastrointestinal tract (from the 
lower part of the duodenum through to the proximal two-thirds of the transverse colon, and 
pancreas); its occlusion is the most direct way of causing intestinal ischaemia. Various SMA 
occlusion techniques have been documented in previous studies for the investigation of 
ischaemic intestinal insults, including ischaemia-reperfusion injuries (14, 22), cytokine 
production and bacteria/endotoxin translocation (16). In our study we performed temporary 
SMA ligation close to its aortic origin to ensure that no collateral circulation from any of its 
branches (inferior pancreaticoduodenal, intestinal, ileocolic, right and middle colic) could 
supply the region of small intestine of interest. Our results showed that within 1-2 min 
following SMA occlusion the current generated by the sensor fell to almost 0 nA, indicating a 
fully hypoxic state. This fall in current will be related to ischaemia and utilisation of the 
residual available O2 by the tissues. Reperfusion of the intestine led to both visual changes in 
the tissue (hyperaemic flush and reoccurrence of mesenteric arterial pulsations) and a rapid 
raise in sensor current, indicating a return of normal oxygenation status to the intestine. This 
shows that the sensor reliably and reproducibly detects tissue hypoxia. 
Following confirmation that changes in intestinal ptO2 could be detected through ischaemic 
insults we determined if alterations in blood oxygenation, through changes in FiO2, could be 
detected. Arterial blood-gas analysis confirmed the expected physiological responses to FiO2 
challenges. Hypoxaemia caused a decrease in PaO2 and SaO2, whereas hyperoxaemia led to 
an increase in their levels. Sensor current readings mirrored these results which changed in 
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accordance with FiO2. Response times, as with ischaemia, were rapid, with the sensor giving 
stable currents 1-2 min after a FiO2 change. 
Although changes in intestinal ptO2 were detected though SMA occlusion and FiO2 alterations, 
no such changes were evident with acute haemorrhage. The reductions in HR and BP 
following 30% removal of circulating blood volume are consistent with increased vagal activity 
and reduced sympathetic input (Bezold–Jarish-like reflex), resulting in a decrease in total 
peripheral resistance. Only with more profound reductions in circulating blood volume is HR 
likely to increase during haemorrhage, representing a transition from reversible to 
irreversible shock (37). Although a slight decrease in Hb concentration was noted with 30% 
haemorrhage, SaO2 levels remained consistent. Stable SaO2 levels were likely due to the 
haemorrhage procedures being performed using an FiO2 of 0.21. This level of SaO2 in 
combination with a decrease in peripheral resistance may have been sufficient to maintain 
intestinal ptO2, which could explain why no change in sensor currents were observed. 
One of the main advantages of our experiments over previous published studies is that they 
were designed not only to assess whether our sensor could detect a change in intestinal ptO2 
following an initial physiological challenge, but also whether sensor readings could reverse to 
baseline levels upon removal of the challenge. Previous work has mainly reported results 
using individual measurements at specific time points (26, 39-41); the continuous recording 
of data performed in this study provided an opportunity to dynamically measure ptO2 changes 
before, during and after each challenge. Our results reproducibly showed that sensor currents 
returned to baseline levels following each challenge. 
For any implantable medical device to gain clinical approval it must undergo biocompatibility 
evaluation to assess biofunctionality (performance) and biosafety (local and systemic tissue 
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responses and the absence of carcinogenesis, mutagenesis and cytotoxicity) (4, 30, 36). 
Following implantation medical devices can lose functionality, largely due to biofouling (non-
specific protein absorption) and the production of granulation and fibrous tissue around the 
implanted device (2). This process, known as the foreign body response (FBR), is composed of 
both acute and chronic inflammatory phases (2, 30, 31) and represents a clinical challenge in 
implantable technology design and development. The materials used in the manufacture of 
the IMPACT sensor have previously undergone extensive biocompatibility in both normal and 
diseased tissues, with results indicating that the materials are well tolerated with a minimal 
FBR elicited when implanted in vivo. These results have led to the use of these materials in a 
variety of medical devices (15). Although the FBR was not evaluated in this study, it is possible 
that acute inflammation could occur through either intestinal manipulation, placement of the 
sensor on the intestinal serosal surface or through the use of tissue glue to secure the sensor 
in place. In order to minimise these potential effects, the intestine was handled as little as 
possible and the glue was placed away from the sensors sensing area. Chronic inflammation 
was also not evaluated in this study largely due to the short-term nature of the experiments; 
however, we anticipate that in a clinical situation the effects from chronic inflammation may 
not be a significant issue. Fibrous reactions that occur around implantable devices occur 
mainly during the chronic inflammatory phase (5-21 days post implantation) (1); as the 
majority of anastomotic leaks occur within the first 8 days post-surgery (18) the use of a long-
term implantable device is unlikely to be needed, this situation would reduce concerns 
regarding the impact that chronic inflammation can have on sensor functionality. 
One potential limitation to these experiments is that both the SMA occlusion technique and 
alterations in FiO2 (0.1 to 1.0) represent extreme experimental insults that may not accurately 
represent physiological ischaemic and hypoxaemic changes that occur following intestinal 
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surgery. However, the primary aim of this study was to validate the ability of the IMPACT 
sensor to measure dynamic changes in intestinal ptO2; our results provide justification to 
progress validation experiments into more complex large animal anastomotic leak models. 
Pigs are regarded as excellent gastrointestinal translational models as they offer similarities 
in size, anatomy and physiology to that of humans and a porcine rectal anastomotic leak 
model has been described in the literature (43). Development of this porcine model could be 
performed for use in future experiments with the IMPACT O2 sensor. These next phase 
experiments would investigate the sensors potential to monitor intestinal ptO2 in normal 
physiological conditions and in those situations associated with an anastomotic leak and 
assess the suitability of the sensors for surgical implantation. Medium to long-term duration 
experiments would also allow the FBR and its effects on sensor functionality to be 
investigated. The use of this model would also allow evaluation of feasibility of placing 
multiple sensors, not only at the anastomotic site, but also at multiple sites along the 
gastrointestinal tract. These studies will elucidate the potential of the sensors to be used in 
human patients for the early detection of anastomotic leakage and the hypoperfusion that 
may precede it. Experiments will also provide clinical, haematological and biochemical 
indicators of anastomotic leakage and the development of septic peritonitis. 
For the IMPACT O2 sensors to be used clinically for resection and anastomotic applications 
investigations will need to be carried out to determine how these sensors could be placed 
intra-operatively, at the anastomotic site, or at multiple sites along the gastrointestinal tract 
so that they remain in situ and are able to measure post-operative intestinal ptO2. Potential 
solutions would include their use akin to a surgical drain or through sensor incorporation into 
surgical staples. Drains are used commonly in anastomotic surgery (20, 33, 35) and are not 
associated with any significant complications. Placed in the region of the anastomotic site, 
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the drains exit the abdominal cavity through a skin incision which are then connected to 
external drainage bags and are easily removed when no longer required. Drains have been 
used to obtain post-operative peritoneal samples from anastomotic sites for measuring 
bacterial colonisation, cytokines (12) and metabolites (32) that might serve as indicators of 
early anastomotic leakage. We propose that designing the IMPACT O2 sensor in a similar 
manner to a surgical drain would allow easy clinical use. The sensors, along with an electrical 
lead (similar in design to the current IMPACT O2 sensor and lead wire), could be positioned 
on the intestine next to the anastomosis site at the time of surgery. The electrical lead would 
then pass out through the skin, like that of a surgical drain, allowing the sensor to be 
connected to the end-of-bed monitor, providing post-operative, real-time data on peri-
anastomotic intestinal ptO2 levels. The sensors could then be removed, in the same way as a 
surgical drain would be, when no longer required. The advantage of this approach would be 
that the IMPACT O2 sensor would not require significant further development. Incorporation 
of IMPACT O2 sensors into staples would have the advantage that peri-anastomotic ptO2 could 
be measured around the entire circumference of the intestine, thus providing detailed spatial 
information. However, further technological development of the sensor through 
miniaturisation and the development of wireless technology would be required in order to 
achieve sensor integration into surgical staples. If these engineering advancements could be 
achieved it would provide opportunities for placing multiple sensors throughout the 
gastrointestinal tract, this concept could be utilised for measuring mucosal ptO2 for other 
intestinal conditions where microenvironmental mucosal hypoxia can influence disease 
outcomes such as chronic intestinal inflammation (42). 
Conclusion 
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Using our developed rodent model of small intestinal ischaemia and hypoxaemia, we 
successfully demonstrated that the IMPACT O2 sensor can detect dynamic changes in 
intestinal oxygenation through ischaemic insults, alterations in FiO2 and euthanasia. These 
miniaturised sensors have significant advantages over Clark O2 sensors previously used in the 
literature as they have the potential be used during surgery and be left in situ following 
surgery to provide post-operative, minimally-invasive, continuous, real-time data regarding 
transitory changes in tissue ptO2. This novel method of monitoring tissue perfusion could, for 
example, detect early peri-anastomotic tissue hypoxia and identify patients that may benefit 
from treatments to improve local oxygenation and prevent a leak. The sensors capability to 
detect dynamic intestinal oxygenation changes could also be used to assess treatment 
responses and, when combined with information gained from conventional monitoring 
systems, would help provide a more accurate assessment of the patient’s condition. We 
expect that this type of visceral surface oximetry will prove clinically useful in the evaluation 
of bowel perfusion and may also be a powerful tool in many other clinical and research 
applications where measurement of organ perfusion is required, for example in transplant 
surgery, chronic intestinal ischaemia and inflammation, plastic surgery and brain injury. 
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Figure and Table Legends 
 
Figure 1. Intra-operative photographs depicting placement of central venous (jugular) and 
arterial (carotid) lines. a) A 2 cm ventral cervical skin incision is made. b&c) Cervical dissection 
is performed for identification and mobilisation of the right jugular vein. d) One untied suture 
is placed distally around the jugular vein and a second is placed proximally and tied securely, 
leaving approximately 1 cm of vein between the 2 sutures. e) A venotomy is created just distal 
to the proximal suture; the cannula is inserted and advanced into the vein approximately 2-3 
cm before tying the distal suture around the vein and cannula. f) Cervical dissection is 
performed for identification of the left carotid artery and its isolation from the vagus nerve. 
g) One untied suture is placed distally around the carotid artery and a second is placed 
proximally and tied securely leaving approximately 1.5 cm of artery between the 2 sutures. A 
small clamp is added just proximal to the distal suture before placing a third untied suture. h) 
An arteriotomy is created between the 2 sutures and the cannula is inserted and advanced 
up to the clamp. i) The third suture is tied loosely over the cannula and the clamp is removed. 
j) The cannula is advanced a further 2 cm before tying the distal suture around the artery and 
cannula. Both vessels were cannulated using 0.96 mm outside diameter PVC tubing (Scientific 
Commodities Inc., Lake Havasu City, AZ, USA) and secured in place with 5-0 silk (Ethicon, UK). 
 
Figure 2. Outline of experimental protocols and interventions. Protocol 1: Control animals 
with no interventions. Protocol 2: Superior mesenteric artery occlusion. Protocol 3: 
Alterations in FiO2, haemorrhage and autotransfusion (resuscitation). Instrumentation 
encompassed: anaesthesia induction, surgical preparation, placement of arterial and venous 
lines and celiotomy. The sensor was placed on the serosal surface of the small intestine 
approximately half way through the stabilisation period. Continuous sensor readings were 
commenced following the achievement of stable baseline physiological variables and 
continued for 15 min following confirmation of death post-euthanasia. 
 
Figure 3. Sensor picture and intra-operative photographs depicting intestinal placement of 
the sensor. a) Macroscopic image of the IMPACT miniaturised O2 sensor. b) Intra-operative 
sensor placement on the serosal surface of a section of small intestine. 
 
Figure 4. Sensor readings and physiological data obtained from control animals (Protocol 
1). a) Current generated at the working electrode of the sensor during continuous sensor 
readings over a period of 165 min; results show mean current readings from the final 5 min 
of each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 
expressed as mean ± SEM, n=3, p=0.7244). b) Physiological data obtained throughout the 
experimental period (Hb: haemoglobin; ABE: arterial base excess; SaO2: haemoglobin O2 
saturation; PaO2: arterial O2 partial pressure; PaCO2: arterial CO2 partial pressure; CT: core 
temperature; RR: respiratory rate; HR: heart rate). 
 
Figure 5. Intra-operative photographs and sensor readings during temporary superior 
mesenteric artery occlusion (Protocol 2). ai) Identification of the SMA originating from the 
left side of the aorta at the level of the right renal vein joining the caudal vena cava; the vessel 
is robust and can withstand the manipulation required for isolation from its surrounding 
tissue and associated vein. aii) A Bulldog clamp was placed across the SMA for temporary 
occlusion. Note the intestinal pallor that was immediately evident upon occlusion. aiii) 
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Following removal of the Bulldog clamp and reinstatement of blood flow, a hyperaemic flush 
was evident to the intestines. b) Representative graph showing current generated at the 
working electrode of the sensor during continuous sensor readings over a period of 70 min. 
Three cycles of 5 min occlusion followed by 10 min of reperfusion were performed in each 
animal before euthanasia. c) Combined analysis comparing current generated at the working 
electrode of the sensor during periods of SMA occlusion and intestinal reperfusion; results 
show mean current readings of the final 3 min of each occlusion period and final 5 min of each 
reperfusion period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 
expressed as mean ± SEM, n=4, **p≤0.01). 
 
Figure 6. Sensor readings and physiological data obtained from assessing intestinal tissue 
oxygenation following changes in inspired O2 concentrations (Protocol 3A). a) 
Representative graph showing current generated at the working electrode of the sensor 
during continuous sensor readings over a period of 150 min. 15 min blocks of each FiO2 
challenge were performed before beginning the removal of 30% of the circulating blood 
volume. b) Combined analysis comparing current generated at the working electrode of the 
sensor during each FiO2 challenge; results show mean current readings of the final 5 min of 
each 15 min period (one-way ANOVA with Holm-Šídák multiple comparisons test; data 
expressed as mean ± SEM, n=5, ****p≤0.0001; *p≤0.05). c&d) Arterial O2 partial pressure, 
total haemoglobin and haemoglobin O2 saturation measured at end of each FiO2 challenge. 
 
Figure 7. Sensor readings and physiological data obtained from assessing intestinal tissue 
oxygenation following progressive haemorrhage and autotransfusion (Protocol 3B). a) 
Combined analysis comparing current generated at the working electrode of the sensor 
during the preceding 15 min baseline period at 21% O2 and the subsequent 2 cycles of removal 
of 15% circulating blood volume followed by autotransfusion; results show mean current 
readings of the final 5 min of each period (one-way ANOVA with Holm-Šídák’s multiple 
comparisons test; data expressed as mean ± SEM, n=5). b&c) Mean arterial blood pressure, 
heart rate, total haemoglobin and haemoglobin O2 saturation measured at end of each of 
intervention period (haem: haemorrhage; Resus: autotransfusion resuscitation). 
 
Table I. Current readings generated during each superior mesenteric artery occlusion and 
reperfusion period and euthanasia (n=4; mean ± SEM). 
 
Table II. Current readings generated during each FiO2 challenge and euthanasia (n=5; mean ± 
SEM). 
 
Table III. Current readings generated during 21% FiO2, each haemorrhage procedure and 
autotransfusion (n=5; mean ± SEM). 
